About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Docs on Twitter


Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« USPTO News: Private PAIR 7.0 and Priority Document Exchange System Web Presentation Delayed | Main | USPTO Begins the "e-Office Action" Pilot Program »

December 19, 2006

GlaxoSmithKline Adds to Antibody Holdings

    By Jason Derry --

GlaxoSmithKline - GSK GlaxoSmithKline Plc. has announced a partnership with Genmab A/S relating to a particular antibody, HuMax-CD20, which is in late-stage clinical development for treating leukemia, lymphoma, and rheumatoid arthritis.  Under the agreement, GSK will give Genmab an upfront payment of $103 million, and will purchase additional shares in the future, bringing the total potential value of the deal to $2.1 billion.

GenMab

The news follows GSK's recently announced acquisition of the antibody therapeutics company, Domantis Ltd.  In that deal, GSK agreed to buy Domantis for $454 million.

Domantis

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 02:42 PM in Biotech/Pharma Business |

Comments

The comments to this entry are closed.

March 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Categories

Archives

More...